Bristol-Myers Squibb Company EV - Enterprise Value 2011-2026 | BMY

Annual EV - Enterprise Value Bristol-Myers Squibb Company

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
184 B	180 B	154 B	211 B	210 B	199 B	210 B	93.7 B	121 B	94.5 B	119 B	113 B	103 B	81.8 B	66.2 B

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
211 B	66.2 B	143 B

EV - Enterprise Value of other stocks in the Biotechnology industry

Issuer	EV - Enterprise Value	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	1.82 B	-	2.43 %	$ 254 M	Germany
ARCA biopharma ABIO	436 M	-	1052.0 %	$ 415 M	USA
Processa Pharmaceuticals PCSA	837 K	$ 2.3	-1.29 %	$ 3.01 M	USA
Aeterna Zentaris AEZS	5.52 M	-	5.93 %	$ 314 M	Canada
Albireo Pharma ALBO	417 M	-	-0.23 %	$ 916 M	USA
Aileron Therapeutics ALRN	33.1 M	-	10.36 %	$ 9.8 M	USA
I-Mab IMAB	8.28 B	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	1.95 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	168 B	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	525 M	-	-13.47 %	$ 169 M	France
Ascendis Pharma A/S ASND	849 M	$ 220.9	2.49 %	$ 5 B	Danmark
Aptinyx APTX	-18.3 M	-	-39.0 %	$ 4.57 M	USA
Midatech Pharma plc MTP	4.79 M	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	3.41 B	-	-1.52 %	$ 24.7 M	USA
Amphastar Pharmaceuticals AMPH	1.92 B	$ 19.57	1.77 %	$ 915 M	USA
Applied Genetic Technologies Corporation AGTC	-9.16 M	-	-	$ 26.5 M	USA
Phathom Pharmaceuticals PHAT	1.55 B	$ 10.47	4.08 %	$ 763 M	USA
Ayala Pharmaceuticals AYLA	5.32 M	-	-	$ 7.46 M	Israel
AgeX Therapeutics AGE	6.28 M	-	-10.17 %	$ 12.2 K	USA
Acorda Therapeutics ACOR	-13.2 M	-	-24.86 %	$ 820 K	USA
Atreca BCEL	94.8 M	-	-11.76 %	$ 5.79 M	USA
Acasti Pharma ACST	24 M	-	4.01 %	$ 150 M	Canada
BeiGene, Ltd. BGNE	-720 M	-	0.49 %	$ 251 B	Cayman-islands
bluebird bio BLUE	270 M	-	-	$ 546 M	USA
Институт стволовых клеток человека ISKJ	14.1 M	-	-	-	Russia
Cara Therapeutics CARA	71.1 M	-	-3.03 %	$ 260 M	USA
Adverum Biotechnologies ADVM	125 M	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	38.2 M	-	2.71 %	$ 14 M	USA
Advaxis ADXS	-3.02 M	-	-9.65 %	$ 45.9 M	USA
Pliant Therapeutics PLRX	80.2 M	$ 1.31	2.34 %	$ 80.4 M	USA
PMV Pharmaceuticals PMVP	59.5 M	$ 1.37	-1.44 %	$ 72 M	USA
Avenue Therapeutics ATXI	-1.23 M	-	-52.27 %	$ 4.45 M	USA
Autolus Therapeutics plc AUTL	1.11 B	$ 1.33	0.76 %	$ 339 M	Britain
Corbus Pharmaceuticals Holdings CRBP	119 M	$ 8.31	1.59 %	$ 111 M	USA
CRISPR Therapeutics AG CRSP	4.38 B	$ 47.09	1.42 %	$ 4.23 B	Schweiz
Cyclacel Pharmaceuticals CYCC	8.71 M	-	-5.98 %	$ 34.1 M	USA
ChemoCentryx CCXI	91.4 M	-	-	$ 3.74 B	USA
Prelude Therapeutics Incorporated PRLD	314 M	$ 3.26	4.49 %	$ 251 M	USA
Dynavax Technologies Corporation DVAX	2.02 B	-	-	$ 2.02 B	USA
ProQR Therapeutics N.V. PRQR	-29 M	$ 1.58	6.04 %	$ 99.5 M	Niderland
BioDelivery Sciences International BDSI	445 M	-	-4.8 %	$ 255 M	USA
Enochian Biosciences ENOB	145 M	-	-	$ 40.5 M	USA
Aeglea BioTherapeutics AGLE	-23.2 M	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	3.19 B	-	-	$ 867 M	Germany
Palatin Technologies PTN	5.56 M	$ 21.0	5.79 %	$ 19.5 M	USA
Bellerophon Therapeutics BLPH	77.1 M	-	-74.18 %	$ 955 K	USA
Akero Therapeutics AKRO	2.99 B	-	-	$ 3.67 B	USA
Pulmatrix PULM	7.09 M	$ 2.12	-1.4 %	$ 7.74 M	USA
Arbutus Biopharma Corporation ABUS	847 M	$ 4.53	5.1 %	$ 868 M	Canada
Homology Medicines FIXX	-28.5 M	-	0.77 %	$ 53.4 M	USA